Managing hyperkalemia in cardiorenal patients: novel therapeutic insights to optimize outcomes
Prof. Weir addresses the need for management of hyperkalemia in CKD patients, discusses RAASi enabling and presents novel therapeutic considerations.
This lecture by prof. Matthew Weir was part of an accredited symposium "RAASi and Hyperkalemia in Cardiorenal Disease: Opportunities for optimizing outcomes" held during ERA-EDTA 2019 in Budapest, Hungary.
Matthew R. Weir, M.D. is attending physician and Director of the Division of Nephrology in the Department of Medicine at the University of Maryland Hospital, Baltimore. He is also Professor of Medicine at the University of Maryland School of Medicine.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Vifor Fresenius Medical Care Renal Pharma.
This is available as accredited online CME for members. Click the button below to enroll:Enroll
Share this page with your colleagues and friends: